Imperva (NASDAQ:IMPV) had its target price increased by research analysts at Imperial Capital from $50.00 to $55.00 in a research report issued on Friday. The brokerage currently has an “outperform” rating on the software maker’s stock. Imperial Capital’s price target points to a potential upside of 18.15% from the company’s previous close.
A number of other research analysts also recently issued reports on the stock. Morgan Stanley boosted their price objective on shares of Imperva from $37.00 to $39.00 and gave the company an “underweight” rating in a research report on Friday. Evercore ISI set a $56.00 price objective on shares of Imperva and gave the company a “buy” rating in a research report on Friday. Piper Jaffray Companies raised shares of Imperva from a “neutral” rating to an “overweight” rating and set a $52.00 price objective on the stock in a research report on Friday. BidaskClub raised shares of Imperva from a “hold” rating to a “buy” rating in a research report on Wednesday. Finally, Zacks Investment Research downgraded shares of Imperva from a “buy” rating to a “hold” rating in a research report on Wednesday, January 10th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have issued a buy rating to the company. Imperva presently has a consensus rating of “Hold” and a consensus price target of $52.93.
Imperva (IMPV) traded up $4.50 during trading hours on Friday, reaching $46.55. 2,140,000 shares of the company were exchanged, compared to its average volume of 279,810. Imperva has a 52 week low of $37.17 and a 52 week high of $52.40. The company has a market cap of $1,580.00, a price-to-earnings ratio of 69.48 and a beta of 1.79.
Large investors have recently added to or reduced their stakes in the company. New York State Common Retirement Fund grew its position in Imperva by 5.3% during the 2nd quarter. New York State Common Retirement Fund now owns 35,800 shares of the software maker’s stock valued at $1,713,000 after purchasing an additional 1,793 shares during the last quarter. Prudential Financial Inc. grew its position in Imperva by 80.7% during the 3rd quarter. Prudential Financial Inc. now owns 54,174 shares of the software maker’s stock valued at $2,351,000 after purchasing an additional 24,190 shares during the last quarter. Wells Fargo & Company MN grew its position in Imperva by 11.9% during the 3rd quarter. Wells Fargo & Company MN now owns 213,953 shares of the software maker’s stock valued at $9,285,000 after purchasing an additional 22,741 shares during the last quarter. American Century Companies Inc. purchased a new stake in Imperva during the 3rd quarter valued at about $6,832,000. Finally, Allianz Asset Management GmbH grew its position in Imperva by 58.1% during the 3rd quarter. Allianz Asset Management GmbH now owns 59,149 shares of the software maker’s stock valued at $2,567,000 after purchasing an additional 21,732 shares during the last quarter. 96.61% of the stock is currently owned by hedge funds and other institutional investors.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.